United States Health Economics and Outcomes Research (HEOR) for Gene Therapy Pricing Market Intel Market Research reports that United States Health Economics and Outcomes Research (HEOR) for Gene Therapy Pricing Market was valued at USD 0.54 billion in 2025, representing roughly 45 % of the global total. The market is projected to expand from USD 0.58 billion in 2026 to USD 1.04 billion by 2034, delivering a robust compound annual growth rate (CAGR) of 8.9 % during the forecast horizon (2025‑2034). https://www.intelmarketresearch.com/download-free-sample/50002/united-states-health-economicsoutcomes-for-gene-therapy-pricing-market

United States Health Economics and Outcomes Research (HEOR) for Gene Therapy Pricing Market Intel Market Research reports that United States Health Economics and Outcomes Research (HEOR) for Gene Therapy Pricing Market was valued at USD 0.54 billion in 2025, representing roughly 45 % of the global total. The market is projected to expand from USD 0.58 billion in 2026 to USD 1.04 billion by 2034, delivering a robust compound annual growth rate (CAGR) of 8.9 % during the forecast horizon (2025‑2034). https://www.intelmarketresearch.com/download-free-sample/50002/united-states-health-economicsoutcomes-for-gene-therapy-pricing-market